\documentclass[10,letterpaperpaper,]{article}

  \title{PrescribeIT Baseline Study}
  \author{Dr.~Neil McEvoy}
  \date{\today}
  


\newcommand{\logo}{HealthEngineerLogo.png}
\newcommand{\cover}{cover.png}
\newcommand{\iblue}{2b4894}
\newcommand{\igray}{d4dbde}

\include{defs}

\begin{document}


\renewcommand{\contentsname}{Inhaltsverzeichnis}

\renewcommand{\pagename}{Seite}


\maketitle

\tableofcontents
\addcontentsline{toc}{section}{Contents} \clearpage

\section{Background to the Study}

The baseline study reported here is the second phase of a three phase
project intended to gather evidence of the benefits of PrescribeIT in
prescribing and dispensing medications.

\subsection{Overall purpose}

The overall purpose of the project is to gather evidence of the benefits
of PrescribeIT.

\subsection{Summary of Phase 1 Workflow}

The first phase examined workflow at selected physician offices and
dispenser outlets. The study identified patterns of flow, and exposed
key processes at which changes due to PrescribeIT might contribute
improvements.

\subsection{Goals of Phase 2 Baseline}

The goal of the second phase is to establish baseline indicators close
to the introduction of PrescribeIT as measures against which future
changes could be compared.

\subsection{Design of Phase 2 Baseline}

The phase uses indicator sets developed in light of the findings of the
initial workflow phase. Each is tailored to the specifics of dispensers
and prescribers repectively.

The indicators were assembled as a secure website designed for secure
yet easy access.

The idnicators are shown in the following tables

\section{Phase 2 Baseline Findings}

The following figures illustrate the base line indicators.

\begin{table}[ht]
\centering
\begin{tabularx}{\textwidth}{|C|C|C|C|C|}
  \rowcolor{igray} \hline
Sepal.Length & Sepal.Width & Petal.Length & Petal.Width & Species \\ 
  \hline
5.10 & 3.50 & 1.40 & 0.20 & setosa \\ 
  4.90 & 3.00 & 1.40 & 0.20 & setosa \\ 
  4.70 & 3.20 & 1.30 & 0.20 & setosa \\ 
  4.60 & 3.10 & 1.50 & 0.20 & setosa \\ 
  5.00 & 3.60 & 1.40 & 0.20 & setosa \\ 
  5.40 & 3.90 & 1.70 & 0.40 & setosa \\ 
  4.60 & 3.40 & 1.40 & 0.30 & setosa \\ 
  5.00 & 3.40 & 1.50 & 0.20 & setosa \\ 
  4.40 & 2.90 & 1.40 & 0.20 & setosa \\ 
  4.90 & 3.10 & 1.50 & 0.10 & setosa \\ 
  5.40 & 3.70 & 1.50 & 0.20 & setosa \\ 
  4.80 & 3.40 & 1.60 & 0.20 & setosa \\ 
  4.80 & 3.00 & 1.40 & 0.10 & setosa \\ 
  4.30 & 3.00 & 1.10 & 0.10 & setosa \\ 
  5.80 & 4.00 & 1.20 & 0.20 & setosa \\ 
  5.70 & 4.40 & 1.50 & 0.40 & setosa \\ 
  5.40 & 3.90 & 1.30 & 0.40 & setosa \\ 
  5.10 & 3.50 & 1.40 & 0.30 & setosa \\ 
  5.70 & 3.80 & 1.70 & 0.30 & setosa \\ 
  5.10 & 3.80 & 1.50 & 0.30 & setosa \\ 
   \hline
\end{tabularx}
\end{table}

\subsection{Selected sites}

The following sites were selected for participation by CHI

Prescribers:

\subsection{Prescribers}

\subsection{Dispensers}

\subsection{Salient findings}

\section{Anticipating Phase 3 Increments}

\subsection{Survey extension}

\subsection{Potential findings}

\section{Reference Materials}


\end{document}
